BERLIN, Germany, September 4 /PRNewswire-FirstCall/ -- Since the tsunami natural disaster in December 2004, Schering AG (FSE: SCH, NYSE: SHR) and its employees have contributed more than EUR 400,000 for immediate and reconstruction aid in Thailand and Indonesia.
As part of the reconstruction aid efforts, a fully furnished orphanage, which will be operated by the Indonesian Rahmania Foundation, has been built in Lhoksumawe, Indonesia, providing a home for 64 children. The children will be trained in practical skills, helping them to start an independent life, once they leave the orphanage. Furthermore a scholarship program for these children has been set up.
On the Thai island Kho Khao, the local health center, "Ban Nok Na", has been rebuilt with Schering's support. It will provide primary medical healthcare for the local population.
These projects, which were selected by the Ernst Schering Foundation in close collaboration with Schering's subsidiaries in the Asia-Pacific region, were successfully concluded with the inauguration of the respective buildings in August 2006.
Schering AG is a research-based pharmaceutical company. Its activities are focused on four business areas: Gynecology&Andrology, Oncology, Diagnostic Imaging as well as Specialized Therapeutics for disabling diseases. As a global player with innovative products Schering AG aims for leading positions in specialized markets worldwide. With in-house R&D and supported by an excellent global network of external partners, Schering AG is securing a promising product pipeline. Using new ideas, Schering AG aims to make a recognized contribution to medical progress and strives to improve the quality of life: making medicine work
This press release has been published by Corporate Communication of Schering AG, Berlin, Germany.
Your contacts at Corporate Communication:
Media Relations:
Oliver Renner, T: +49-30-468-124-31,
Gabriele Liebmann-El Badry, T: +49-30-468-156-25,
Find additional information at: www.schering.de/eng
Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and Schering AG's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. Certain factors that may cause such differences are discussed in our Form 20-F and Form 6-K reports filed with the U.S. Securities and Exchange Commission. Schering AG undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise.
